Supernus Pharmaceuticals (SUPN - Get Report) is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. This stock is trading up 9.9% to $5.66 in recent trading.
Today's Range: $5.15-$5.7452-Week Range: $4.30-$7.01 Volume: 53,000 Three-Month Average Volume: 67,079 From a technical perspective, shares of SUPN are soaring here with decent volume, and the stock has started to enter breakout territory with shares moving above some near-term overhead resistance at $5.45. >>22 Biopharma Stocks With Breakout Potential in 2012 Traders should now look for long-biased trades as long as SUPN is trending above $5.45 with strong upside volume flows. I would consider any upside volume day that registers near or above 67,079 shares as bullish. If we continue to see that action, then look for SUPN to re-test and possibly take out its next significant overheard resistance levels at $6.10 to $6.50 in the near future. If we get that action, and $6.50 gets taken out with volume, then look for even more upside once SUPN takes out its all-time high of $7.